Antibody Diversity in Cancer: Translational Implications and Beyond
Authors:
Open Access
Abstract
Patients with cancer tend to develop antibodies to autologous proteins. This phenomenon has been observed across multiple cancer types, including bladder, lung, colon, prostate, and melanoma. These antibodies potentially arise due to induced inflammation or an increase in self-antigens. Studies focusing on antibody diversity are particularly attractive for their diagnostic value considering antibodies are present at an early diseased stage, serum samples are relatively easy to obtain, and the prevalence of antibodies is high even when the target antigen is minimally expressed. Conversely, the surveillance of serum proteins in cancer patients is relatively challenging because they often show variability in expression and are less abundant. Moreover, an antibody’s presence is also useful as it suggests the relative immunogenicity of a given antigen. For these reasons, profiling antibodies’ responses is actively considered to detect the spread of antigens following immunotherapy. The current review focuses on expanding the knowledge of antibodies and their diversity, and the impact of antibody diversity on cancer regression and progression.Keywords
Funding Information
- American Urological Association Southeastern Section Research Scholar Award
- Sylvester Comprehensive Cancer Center Inter-Programmatic Cancer Research
This publication has 111 references indexed in Scilit:
- B Cells Promote Tumor Progression via STAT3 Regulated-AngiogenesisPLOS ONE, 2013
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Second Malignancy Risks After Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: Differences by Lymphoma SubtypeJournal of Clinical Oncology, 2010
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancerNature, 2010
- Overview of the immune responseJournal of Allergy and Clinical Immunology, 2010
- FcRγ Activation Regulates Inflammation-Associated Squamous CarcinogenesisCancer Cell, 2010
- Pathogenesis, Diagnosis, and Management of Primary Antibody Deficiencies and InfectionsClinical Microbiology Reviews, 2009
- A systematic review of humoral immune responses against tumor antigensCancer Immunology, Immunotherapy, 2009
- Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung CancerClinical Cancer Research, 2008
- B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activationBlood, 2006